journal article Dec 01, 2004

Plasma terminal half‐life

View at Publisher Save 10.1111/j.1365-2885.2004.00600.x
Abstract
Terminal plasma half‐life is the time required to divide the plasma concentration by two after reaching pseudo‐equilibrium, and not the time required to eliminate half the administered dose. When the process of absorption is not a limiting factor, half‐life is a hybrid parameter controlled by plasma clearance and extent of distribution. In contrast, when the process of absorption is a limiting factor, the terminal half‐life reflects rate and extent of absorption and not the elimination process (flip‐flop pharmacokinetics). The terminal half‐life is especially relevant to multiple dosing regimens, because it controls the degree of drug accumulation, concentration fluctuations and the time taken to reach equilibrium.
Topics

No keywords indexed for this article. Browse by subject →

References
11
[9]
Toutain P.L. "Pharmacokinetics and residue levels of phenylbutazone in the cow" Annales de Recherches Vetetrinaires (1980)
[10]
Toutain P.L. "Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland" American Journal of Veterinary Research (1984)
Metrics
281
Citations
11
References
Details
Published
Dec 01, 2004
Vol/Issue
27(6)
Pages
427-439
License
View
Cite This Article
P. L. TOUTAIN, A. BOUSQUET‐MÉLOU (2004). Plasma terminal half‐life. Journal of Veterinary Pharmacology and Therapeutics, 27(6), 427-439. https://doi.org/10.1111/j.1365-2885.2004.00600.x
Related

You May Also Like

Plasma clearance

P. L. TOUTAIN, A. BOUSQUET‐MÉLOU · 2004

266 citations

Current review of isoxazoline ectoparasiticides used in veterinary medicine

Xueying Zhou, Alexandra E. Hohman · 2021

93 citations

Antimicrobial resistance in livestock

B. Catry, H. Laevens · 2003

91 citations

A history of antimicrobial drugs in animals: Evolution and revolution

Peter Lees, Ludovic Pelligand · 2020

71 citations

Canine obesity – an overview

J. GOSSELLIN, J. A. WREN · 2007

62 citations